Internal database tool for classification of commercialized and pipeline genetic and cell therapies

Authors

Carolyn ZhengFollow

Faculty Advisor

Dave Tabors

Document Type

Report

Publication Date

Fall 9-14-2020

Abstract

Clarion Healthcare has been building internal expertise in genetic and cell therapies, novel treatment options for rare diseases. The focus of this ENGG 390 project was to increase the firm’s secondary research efficiencies in this area, improving their quality of client work while cutting down on costs. Thousands of data entries on genetic and cell therapies were analyzed to identify a comprehensive classification structure to capture the technologies in space. An excel database tool was created, capable of analyzing the data exports, classifying them by therapy type, therapy specific subtypes, and technology type, allowing for improved data management and cutting down on analysis time.

Level of Access

Restricted: Campus/Dartmouth Community Only Access

Dartmouth Digital Commons Citation

Zheng, Carolyn, "Internal database tool for classification of commercialized and pipeline genetic and cell therapies" (2020). ENGG 390 Reports (MEM Students). 100.
https://digitalcommons.dartmouth.edu/engs390/100